ΠΦΥ -Εκπαίδευση > Αποσπάσματα από τον έντυπο & ηλεκτρονικό τύπο

Apixaban vs. Warfarin in Patients with Thrombotic Antiphospholipid Antibody Synd

(1/1)

Argirios Argiriou:
Apixaban vs. Warfarin in Patients with Thrombotic Antiphospholipid Antibody Syndrome

Brady L. Stein, MD, MHS, reviewing Woller SC et al. Blood Adv 2021 Oct 18

Patients treated with apixaban were more likely to experience arterial thrombosis than those treated with warfarin.

Δεν είναι ορατοί οι σύνδεσμοι (links). Εγγραφή ή Είσοδος

Πλοήγηση

[0] Λίστα μηνυμάτων